Search

everythinglearnresearchcommunity

for

Search:↓

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

HFMs can help study hair growth and test potential hair growth drugs.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Dermoscopy helps diagnose folliculotropic mycosis fungoides by identifying specific skin patterns.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Laser hair reduction can sometimes cause a rare skin condition called Fox-Fordyce disease.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

FFA and FAPD might be related or stages of the same disease.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Fascial Manipulation treatment helped a woman with vulvodynia and other health issues.

The patient has frontal fibrosing alopecia (FFA).